Ryanodine receptors

Skeletal Muscle

Volumn 1, Issue 1, 2011, Pages

  Capes, E Michelle ^a   Loaiza, Randall ^a   Valdivia, Héctor H ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83455161056     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/2044-5040-1-18     Document Type: Review

References (162)

1. Benitah JP, Alvarez JL, Gomez AM. L-type Ca(2+) current in ventricular cardiomyocytes. J Mol Cell Cardiol 2010, 48:26-36. 10.1016/j.yjmcc.2009.07.026, 19660468.
2. Lorenzon NM, Beam KG. Disease causing mutations of calcium channels. Channels (Austin) 2008, 2:163-179.
3. Lanner JT, Georgiou DK, Joshi AD, Hamilton SL. Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol 2010,
4. Coronado R, Morrissette J, Sukhareva M, Vaughan DM. Structure and function of ryanodine receptors. Am J Physiol 1994, 266:C1485-1504.
5. Hakamata Y, Nakai J, Takeshima H, Imoto K. Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain. FEBS Lett 1992, 312:229-235. 10.1016/0014-5793(92)80941-9, 1330694.
6. Nakai J, Sekiguchi N, Rando TA, Allen PD, Beam KG. Two regions of the ryanodine receptor involved in coupling with L-type Ca2+ channels. J Biol Chem 1998, 273:13403-13406. 10.1074/jbc.273.22.13403, 9593671.
7. Perez CF, Mukherjee S, Allen PD. Amino acids 1-1,680 of ryanodine receptor type 1 hold critical determinants of skeletal type for excitation-contraction coupling. Journal of Biological Chemistry 2003, 278:39644-39652. 10.1074/jbc.M305160200, 12900411.
8. Hayek SM, Zhao J, Bhat M, Xu X, Nagaraj R, Pan Z, Takeshima H, Ma J. A negatively charged region of the skeletal muscle ryanodine receptor is involved in Ca(2+)-dependent regulation of the Ca(2+) release channel. FEBS Lett 1999, 461:157-164. 10.1016/S0014-5793(99)01464-7, 10567689.
9. Hamilton SL, Serysheva II. Ryanodine receptor structure: progress and challenges. J Biol Chem 2009, 284:4047-4051.
10. Wagenknecht T, Samso M. Three-dimensional reconstruction of ryanodine receptors. Front Biosci 2002, 7:d1464-1474. 10.2741/wagen, 12045016.
11. Samso M, Feng W, Pessah IN, Allen PD. Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol 2009, 7:e85. 10.1371/journal.pbio.1000085, 2672603, 19402748.
12. Samso M, Shen X, Allen PD. Structural characterization of the RyR1-FKBP12 interaction. J Mol Biol 2006, 356:917-927. 10.1016/j.jmb.2005.12.023, 16405911.
13. Samso M, Wagenknecht T, Allen PD. Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-EM. Nat Struct Mol Biol 2005, 12:539-544. 10.1038/nsmb938, 1925259, 15908964.
14. Welch W, Rheault S, West DJ, Williams AJ. A model of the putative pore region of the cardiac ryanodine receptor channel. Biophys J 2004, 87:2335-2351. 10.1529/biophysj.104.044180, 1304657, 15454434.
15. Amador FJ, Liu S, Ishiyama N, Plevin MJ, Wilson A, MacLennan DH, Ikura M. Crystal structure of type I ryanodine receptor amino-terminal β-trefoil domain reveals a disease-associated mutation "hot spot" loop. Proceedings of the National Academy of Sciences 2009, 106:11040-11044.
16. Lobo PA, Van Petegem F. Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations. Structure 2009, 17:1505-1514. 10.1016/j.str.2009.08.016, 19913485.
17. Tung CC, Lobo PA, Kimlicka L, Van Petegem F. The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature 2010,
18. Inui M, Saito A, Fleischer S. Purification of the ryanodine receptor and identity with feet structures of junctional terminal cisternae of sarcoplasmic reticulum from fast skeletal muscle. J Biol Chem 1987, 262:1740-1747.
19. Lai FA, Erickson HP, Rousseau E, Liu QY, Meissner G. Purification and reconstitution of the calcium release channel from skeletal muscle. Nature 1988, 331:315-319. 10.1038/331315a0, 2448641.
20. Wagenknecht T, Grassucci R, Frank J, Saito A, Inui M, Fleischer S. Three-dimensional architecture of the calcium channel/foot structure of sarcoplasmic reticulum. Nature 1989, 338:167-170. 10.1038/338167a0, 2537473.
21. Serysheva II. Structural insights into excitation-contraction coupling by electron cryomicroscopy. Biochemistry (Mosc) 2004, 69:1226-1232.
22. Franzini-Armstrong C, Protasi F, Ramesh V. Comparative ultrastructure of Ca2+ release units in skeletal and cardiac muscle. Ann N Y Acad Sci 1998, 853:20-30. 10.1111/j.1749-6632.1998.tb08253.x, 10603933.
23. Orlova EV, van Heel M, Hamilton SL, Chiu W. Two structural configurations of the skeletal muscle calcium release channel. Nat Struct Biol 1996, 3:547-552. 10.1038/nsb0696-547, 8646541.
24. Serysheva II, Ludtke SJ, Baker ML, Cong Y, Topf M, Eramian D, Sali A, Hamilton SL, Chiu W. Subnanometer-resolution electron cryomicroscopy-based domain models for the cytoplasmic region of skeletal muscle RyR channel. Proceedings of the National Academy of Sciences 2008, 105:9610-9615.
25. Schatz M, van Heel M, Chiu W, Hamilton SL. Structure of the skeletal muscle calcium release channel activated with Ca2+ and AMP-PCP. Biophys J 1999, 77:1936-1944. 10.1016/S0006-3495(99)77035-9, 1300475, 10512814.
26. Fill M, Copello JA. Ryanodine receptor calcium release channels. Physiol Rev 2002, 82:893-922.
27. Du W, McMahon TJ, Zhang ZS, Stiber JA, Meissner G, Eu JP. Excitation-contraction coupling in airway smooth muscle. J Biol Chem 2006, 281:30143-30151. 10.1074/jbc.M606541200, 16891657.
28. Ludtke SJ, Hamilton SL, Chiu W. The pore structure of the closed RyR1 channel. Structure 2005, 13:1203-1211. 10.1016/j.str.2005.06.005, 2983469, 16084392.
29. Yamamoto T, El-Hayek R, Ikemoto N. Postulated role of interdomain interaction within the ryanodine receptor in Ca(2+) channel regulation. J Biol Chem 2000, 275:11618-11625. 10.1074/jbc.275.16.11618, 10766778.
30. Ikemoto N, Yamamoto T. Postulated role of inter-domain interaction within the ryanodine receptor in Ca(2+) channel regulation. Trends Cardiovasc Med 2000, 10:310-316. 10.1016/S1050-1738(01)00067-6, 11343972.
31. Ikemoto N, Yamamoto T. Regulation of calcium release by interdomain interaction within ryanodine receptors. Front Biosci 2002, 7:d671-683. 10.2741/ikemoto, 11861212.
32. Bers DM. Macromolecular complexes regulating cardiac ryanodine receptor function. Journal of Molecular and Cellular Cardiology 2004, 37:417-429. 10.1016/j.yjmcc.2004.05.026, 15276012.
33. Yin C-C, D'Cruz LG, Lai FA. Ryanodine receptor arrays: not just a pretty pattern?. Trends in Cell Biology 2008, 18:149-156. 10.1016/j.tcb.2008.02.003, 18329877.
34. Bers DM, Li L, Satoh H, McCall E. Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes. Ann N Y Acad Sci 1998, 853:157-177. 10.1111/j.1749-6632.1998.tb08264.x, 10603944.
35. Tripathy A, Xu L, Mann G, Meissner G. Calmodulin activation and inhibition of skeletal muscle Ca2+ release channel (ryanodine receptor). Biophys J 1995, 69:106-119. 10.1016/S0006-3495(95)79880-0, 1236229, 7669888.
36. Brillantes AB, Ondrias K, Scott A, Kobrinsky E, Ondriasova E, Moschella MC, Jayaraman T, Landers M, Ehrlich BE, Marks AR. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 1994, 77:513-523. 10.1016/0092-8674(94)90214-3, 7514503.
37. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000, 101:365-376. 10.1016/S0092-8674(00)80847-8, 10830164.
38. Xiao J, Tian X, Jones PP, Bolstad J, Kong H, Wang R, Zhang L, Duff HJ, Gillis AM, Fleischer S, et al. Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias. J Biol Chem 2007, 282:34828-34838. 10.1074/jbc.M707423200, 2760432, 17921453.
39. Goonasekera SA, Beard NA, Groom L, Kimura T, Lyfenko AD, Rosenfeld A, Marty I, Dulhunty AF, Dirksen RT. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling. J Gen Physiol 2007, 130:365-378. 10.1085/jgp.200709790, 2151650, 17846166.
40. Guo W, Campbell KP. Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum. J Biol Chem 1995, 270:9027-9030. 10.1074/jbc.270.16.9027, 7721813.
41. Gyorke I, Hester N, Jones LR, Gyorke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 2004, 86:2121-2128. 10.1016/S0006-3495(04)74271-X, 1304063, 15041652.
42. Shin DW, Ma J, Kim DH. The asp-rich region at the carboxyl-terminus of calsequestrin binds to Ca2+ and interacts with triadin. FEBS Letters 2000, 486:178-182. 10.1016/S0014-5793(00)02246-8, 11113462.
43. Wei L, Gallant EM, Dulhunty AF, Beard NA. Junctin and triadin each activate skeletal ryanodine receptors but junctin alone mediates functional interactions with calsequestrin. The International Journal of Biochemistry & Cell Biology 2009, 41:2214-2224. 10.1016/j.biocel.2009.04.017, 20833257.
44. Yuan Q, Fan GC, Dong M, Altschafl B, Diwan A, Ren X, Hahn HH, Zhao W, Waggoner JR, Jones LR, et al. Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity. Circulation 2007, 115:300-309. 10.1161/CIRCULATIONAHA.106.654699, 17224479.
45. Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997, 272:23389-23397. 10.1074/jbc.272.37.23389, 9287354.
46. Qin J, Valle G, Nani A, Chen H, Ramos-Franco J, Nori A, Volpe P, Fill M. Ryanodine receptor luminal Ca2+ regulation: swapping calsequestrin and channel isoforms. Biophys J 2009, 97:1961-1970. 10.1016/j.bpj.2009.07.030, 2756356, 19804727.
47. Royer L, Rios E. Deconstructing calsequestrin. Complex buffering in the calcium store of skeletal muscle. J Physiol 2009, 587:3101-3111. 10.1113/jphysiol.2009.171934, 2727020, 19403601.
48. Lehnart SE, Wehrens XH, Reiken S, Warrier S, Belevych AE, Harvey RD, Richter W, Jin SL, Conti M, Marks AR. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 2005, 123:25-35. 10.1016/j.cell.2005.07.030, 2901878, 16213210.
49. Farrell EF, Antaramian A, Rueda A, Gomez AM, Valdivia HH. Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. J Biol Chem 2003, 278:34660-34666. 10.1074/jbc.M305931200, 12824171.
50. Meyers MB, Pickel VM, Sheu SS, Sharma VK, Scotto KW, Fishman GI. Association of sorcin with the cardiac ryanodine receptor. J Biol Chem 1995, 270:26411-26418. 10.1074/jbc.270.44.26411, 7592856.
51. Jones PP, Meng X, Xiao B, Cai S, Bolstad J, Wagenknecht T, Liu Z, Chen SR. Localization of PKA phosphorylation site, Ser(2030), in the three-dimensional structure of cardiac ryanodine receptor. Biochem J 2008, 410:261-270. 10.1042/BJ20071257, 2791347, 17967164.
52. Meng X, Xiao B, Cai S, Huang X, Li F, Bolstad J, Trujillo R, Airey J, Chen SRW, Wagenknecht T, Liu Z. Three-dimensional localization of serine 2808, a phosphorylation site in cardiac ryanodine receptor. Journal of Biological Chemistry 2007, 282:25929-25939. 10.1074/jbc.M704474200, 2796423, 17606610.
53. Feng W, Tu J, Pouliquin P, Cabrales E, Shen X, Dulhunty A, Worley PF, Allen PD, Pessah IN. Dynamic regulation of ryanodine receptor type 1 (RyR1) channel activity by Homer 1. Cell Calcium 2008, 43:307-314. 10.1016/j.ceca.2007.06.001, 2288792, 17707505.
54. Pouliquin P, Pace S, Dulhunty A. In vitro modulation of the cardiac ryanodine receptor activity by Homer1. Pflügers Archiv European Journal of Physiology 2009, 458:723-732. 10.1007/s00424-009-0664-0, 21536790.
55. Worley PF, Zeng W, Huang G, Kim JY, Shin DM, Kim MS, Yuan JP, Kiselyov K, Muallem S. Homer proteins in Ca2+ signaling by excitable and non-excitable cells. Cell Calcium 2007, 42:363-371. 10.1016/j.ceca.2007.05.007, 2100435, 17618683.
56. Moore CP, Rodney G, Zhang JZ, Santacruz-Toloza L, Strasburg G, Hamilton SL. Apocalmodulin and Ca2+ calmodulin bind to the same region on the skeletal muscle Ca2+ release channel. Biochemistry 1999, 38:8532-8537. 10.1021/bi9907431, 10387100.
57. Wagenknecht T, Radermacher M, Grassucci R, Berkowitz J, Xin HB, Fleischer S. Locations of calmodulin and FK506-binding protein on the three-dimensional architecture of the skeletal muscle ryanodine receptor. J Biol Chem 1997, 272:32463-32471. 10.1074/jbc.272.51.32463, 9405457.
58. Samso M, Wagenknecht T. Apocalmodulin and Ca2+-calmodulin bind to neighboring locations on the ryanodine receptor. J Biol Chem 2002, 277:1349-1353. 10.1074/jbc.M109196200, 11694536.
59. Cornea RL, Nitu FR, Samso M, Thomas DD, Fruen BR. Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer. J Biol Chem 2010, 285:19219-19226. 10.1074/jbc.M109.066944, 20404344.
60. Collins JH. Sequence analysis of the ryanodine receptor: possible association with a 12K, FK506-binding immunophilin/protein kinase C inhibitor. Biochem Biophys Res Commun 1991, 178:1288-1290. 10.1016/0006-291X(91)91033-9, 1872849.
61. Jayaraman T, Brillantes AM, Timerman AP, Fleischer S, Erdjument-Bromage H, Tempst P, Marks AR. FK506 binding protein associated with the calcium release channel (ryanodine receptor). Journal of Biological Chemistry 1992, 267:9474-9477.
62. Bultynck G, Rossi D, Callewaert G, Missiaen L, Sorrentino V, Parys JB, De Smedt H. The conserved sites for the FK506-binding proteins in ryanodine receptors and inositol 1,4,5-trisphosphate receptors are structurally and functionally different. J Biol Chem 2001, 276:47715-47724. 10.1074/jbc.M106573200, 11598113.
63. Gaburjakova M, Gaburjakova J, Reiken S, Huang F, Marx SO, Rosemblit N, Marks AR. FKBP12 binding modulates ryanodine receptor channel gating. J Biol Chem 2001, 276:16931-16935. 10.1074/jbc.M100856200, 11279144.
64. Masumiya H, Wang R, Zhang J, Xiao B, Chen SR. Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor). J Biol Chem 2003, 278:3786-3792. 10.1074/jbc.M210962200, 12446682.
65. Zhang J, Liu Z, Masumiya H, Wang R, Jiang D, Li F, Wagenknecht T, Chen SR. Three-dimensional localization of divergent region 3 of the ryanodine receptor to the clamp-shaped structures adjacent to the FKBP binding sites. J Biol Chem 2003, 278:14211-14218. 10.1074/jbc.M213164200, 12576471.
66. Zissimopoulos S, Lai FA. Interaction of FKBP12.6 with the cardiac ryanodine receptor C-terminal domain. J Biol Chem 2005, 280:5475-5485.
67. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 1983, 245:C1-14.
68. Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J Gen Physiol 1985, 85:247-289. 10.1085/jgp.85.2.247, 2215800, 2580043.
69. Armstrong CM, Bezanilla FM, Horowicz P. Twitches in the presence of ethylene glycol bis(-aminoethyl ether)-N,N'-tetracetic acid. Biochim Biophys Acta 1972, 267:605-608. 10.1016/0005-2728(72)90194-6, 4537984.
70. Rios E, Ma JJ, Gonzalez A. The mechanical hypothesis of excitation-contraction (EC) coupling in skeletal muscle. J Muscle Res Cell Motil 1991, 12:127-135. 10.1007/BF01774031, 1648106.
71. Knudson CM, Chaudhari N, Sharp AH, Powell JA, Beam KG, Campbell KP. Specific absence of the alpha 1 subunit of the dihydropyridine receptor in mice with muscular dysgenesis. J Biol Chem 1989, 264:1345-1348.
72. Stern MD, Pizarro G, Rios E. Local control model of excitation-contraction coupling in skeletal muscle. J Gen Physiol 1997, 110:415-440. 10.1085/jgp.110.4.415, 2229377, 9379173.
73. Gyorke S, Fill M. Ryanodine receptor adaptation: control mechanism of Ca(2+)-induced Ca2+ release in heart. Science 1993, 260:807-809. 10.1126/science.8387229, 8387229.
74. Valdivia HH, Kaplan JH, Ellis-Davies GC, Lederer WJ. Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation. Science 1995, 267:1997-2000. 10.1126/science.7701323, 7701323.
75. Velez P, Gyorke S, Escobar AL, Vergara J, Fill M. Adaptation of single cardiac ryanodine receptor channels. Biophys J 1997, 72:691-697. 10.1016/S0006-3495(97)78705-8, 1185594, 9017196.
76. Chu A, Fill M, Stefani E, Entman ML. Cytoplasmic Ca2+ does not inhibit the cardiac muscle sarcoplasmic reticulum ryanodine receptor Ca2+ channel, although Ca(2+)-induced Ca2+ inactivation of Ca2+ release is observed in native vesicles. J Membr Biol 1993, 135:49-59.
77. Fill M, Coronado R, Mickelson JR, Vilven J, Ma JJ, Jacobson BA, Louis CF. Abnormal ryanodine receptor channels in malignant hyperthermia. Biophys J 1990, 57:471-475. 10.1016/S0006-3495(90)82563-7, 1280741, 2306496.
78. Sonnleitner A, Conti A, Bertocchini F, Schindler H, Sorrentino V. Functional properties of the ryanodine receptor type 3 (RyR3) Ca2+ release channel. EMBO J 1998, 17:2790-2798. 10.1093/emboj/17.10.2790, 1170619, 9582272.
79. Bull R, Marengo JJ. Sarcoplasmic reticulum release channels from frog skeletal muscle display two types of calcium dependence. FEBS Lett 1993, 331:223-227. 10.1016/0014-5793(93)80341-Q, 8397110.
80. Copello JA, Barg S, Onoue H, Fleischer S. Heterogeneity of Ca2+ gating of skeletal muscle and cardiac ryanodine receptors. Biophys J 1997, 73:141-156. 10.1016/S0006-3495(97)78055-X, 1180916, 9199779.
81. Meissner G, Darling E, Eveleth J. Kinetics of rapid Ca2+ release by sarcoplasmic reticulum. Effects of Ca2+, Mg2+, and adenine nucleotides. Biochemistry 1986, 25:236-244. 10.1021/bi00349a033, 3754147.
82. Gyorke S, Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc Res 2008, 77:245-255.
83. Shannon TR, Bers DM. Assessment of intra-SR free [Ca] and buffering in rat heart. Biophys J 1997, 73:1524-1531. 10.1016/S0006-3495(97)78184-0, 1181051, 9284319.
84. Donoso P, Prieto H, Hidalgo C. Luminal calcium regulates calcium release in triads isolated from frog and rabbit skeletal muscle. Biophys J 1995, 68:507-515. 10.1016/S0006-3495(95)80212-2, 1281715, 7696504.
85. Laver DR, O'Neill ER, Lamb GD. Luminal Ca2+-regulated Mg2+ inhibition of skeletal RyRs reconstituted as isolated channels or coupled clusters. J Gen Physiol 2004, 124:741-758. 10.1085/jgp.200409092, 2234024, 15545399.
86. Witcher DR, Kovacs RJ, Schulman H, Cefali DC, Jones LR. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J Biol Chem 1991, 266:11144-11152.
87. Yoshida A, Takahashi M, Imagawa T, Shigekawa M, Takisawa H, Nakamura T. Phosphorylation of ryanodine receptors in rat myocytes during beta-adrenergic stimulation. J Biochem 1992, 111:186-190.
88. Benkusky NA, Weber CS, Scherman JA, Farrell EF, Hacker TA, John MC, Powers PA, Valdivia HH. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circ Res 2007, 101:819-829. 10.1161/CIRCRESAHA.107.153007, 17717301.
89. Li Y, Kranias EG, Mignery GA, Bers DM. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ Res 2002, 90:309-316. 10.1161/hh0302.105660, 11861420.
90. Reiken S, Lacampagne A, Zhou H, Kherani A, Lehnart SE, Ward C, Huang F, Gaburjakova M, Gaburjakova J, Rosemblit N, et al. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. J Cell Biol 2003, 160:919-928. 10.1083/jcb.200211012, 2173774, 12629052.
91. Wehrens XH, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ, Sun J, Guatimosim S, Song LS, Rosemblit N, et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003, 113:829-840. 10.1016/S0092-8674(03)00434-3, 12837242.
92. Hain J, Onoue H, Mayrleitner M, Fleischer S, Schindler H. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J Biol Chem 1995, 270:2074-2081. 10.1074/jbc.270.5.2074, 7836435.
93. Terentyev D, Viatchenko-Karpinski S, Gyorke I, Terentyeva R, Gyorke S. Protein phosphatases decrease sarcoplasmic reticulum calcium content by stimulating calcium release in cardiac myocytes. J Physiol 2003, 552:109-118. 10.1113/jphysiol.2003.046367, 2343319, 12897175.
94. Stange M, Xu L, Balshaw D, Yamaguchi N, Meissner G. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. J Biol Chem 2003, 278:51693-51702. 10.1074/jbc.M310406200, 14532276.
95. Wehrens XH, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci USA 2006, 103:511-518. 10.1073/pnas.0510113103, 1334677, 16407108.
96. Wehrens XH, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 2004, 304:292-296. 10.1126/science.1094301, 15073377.
97. Xiao B, Zhong G, Obayashi M, Yang D, Chen K, Walsh MP, Shimoni Y, Cheng H, Ter Keurs H, Chen SR. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts. Biochem J 2006, 396:7-16. 10.1042/BJ20060116, 1449991, 16483256.
98. Ginsburg KS, Bers DM. Modulation of excitation-contraction coupling by isoproterenol in cardiomyocytes with controlled SR Ca2+ load and Ca2+ current trigger. J Physiol 2004, 556:463-480. 10.1113/jphysiol.2003.055384, 1664945, 14724205.
99. Blazev R, Hussain M, Bakker AJ, Head SI, Lamb GD. Effects of the PKA inhibitor H-89 on excitation-contraction coupling in skinned and intact skeletal muscle fibres. J Muscle Res Cell Motil 2001, 22:277-286. 10.1023/A:1012289526618, 11763200.
100. Shan J, Betzenhauser MJ, Kushnir A, Reiken S, Meli AC, Wronska A, Dura M, Chen BX, Marks AR. Role of chronic ryanodine receptor phosphorylation in heart failure and beta-adrenergic receptor blockade in mice. J Clin Invest 2010, 120:4375-4387. 10.1172/JCI37649, 2993577, 21099115.
101. O'Connell KM, Yamaguchi N, Meissner G, Dirksen RT. Calmodulin binding to the 3614-3643 region of RyR1 is not essential for excitation-contraction coupling in skeletal myotubes. J Gen Physiol 2002, 120:337-347. 10.1085/jgp.20028617, 2229515, 12198090.
102. Eu JP, Sun J, Xu L, Stamler JS, Meissner G. The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell 2000, 102:499-509. 10.1016/S0092-8674(00)00054-4, 10966111.
103. Wright NT, Prosser BL, Varney KM, Zimmer DB, Schneider MF, Weber DJ. S100A1 and calmodulin compete for the same binding site on ryanodine receptor. J Biol Chem 2008, 283:26676-26683. 10.1074/jbc.M804432200, 2546546, 18650434.
104. Prosser BL, Wright NT, Hernandez-Ochoa EO, Varney KM, Liu Y, Olojo RO, Zimmer DB, Weber DJ, Schneider MF. S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling. J Biol Chem 2008, 283:5046-5057.
105. Gusev K, Ackermann GE, Heizmann CW, Niggli E. Ca2+ signaling in mouse cardiomyocytes with ablated S100A1 protein. Gen Physiol Biophys 2009, 28:371-383. 10.4149/gpb_2009_04_371, 20097960.
106. Remppis A, Most P, Loffler E, Ehlermann P, Bernotat J, Pleger S, Borries M, Reppel M, Fischer J, Koch WJ, et al. The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes. Basic Res Cardiol 2002, 97(Suppl 1):I56-62.
107. Most P, Seifert H, Gao E, Funakoshi H, Volkers M, Heierhorst J, Remppis A, Pleger ST, DeGeorge BR, Eckhart AD, et al. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation 2006, 114:1258-1268. 10.1161/CIRCULATIONAHA.106.622415, 16952982.
108. Ono M, Yano M, Hino A, Suetomi T, Xu X, Susa T, Uchinoumi H, Tateishi H, Oda T, Okuda S, et al. Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure. Cardiovasc Res 2010, 87:609-617. 10.1093/cvr/cvq108, 20388639.
109. Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998, 279:234-237. 10.1126/science.279.5348.234, 9422697.
110. Aracena P, Sanchez G, Donoso P, Hamilton SL, Hidalgo C. S-glutathionylation decreases Mg2+ inhibition and S-nitrosylation enhances Ca2+ activation of RyR1 channels. J Biol Chem 2003, 278:42927-42935. 10.1074/jbc.M306969200, 12920114.
111. Sun J, Yamaguchi N, Xu L, Eu JP, Stamler JS, Meissner G. Regulation of the cardiac muscle ryanodine receptor by O(2) tension and S-nitrosoglutathione. Biochemistry 2008, 47:13985-13990. 10.1021/bi8012627, 2636679, 19053230.
112. Aracena-Parks P, Goonasekera SA, Gilman CP, Dirksen RT, Hidalgo C, Hamilton SL. Identification of cysteines involved in s-nitrosylation, s-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. Journal of Biological Chemistry 2006, 281:40354-40368. 10.1074/jbc.M600876200, 17071618.
113. Gonzalez DR, Fernandez IC, Ordenes PP, Treuer AV, Eller G, Boric MP. Differential role of S-nitrosylation and the NO-cGMP-PKG pathway in cardiac contractility. Nitric Oxide 2008, 18:157-167.
114. Ziolo MT. The fork in the nitric oxide road: cyclic GMP or nitrosylation?. Nitric Oxide 2008, 18:153-156. 10.1016/j.niox.2008.01.008, 2366797, 18312860.
115. Wang H, Viatchenko-Karpinski S, Sun J, Gyorke I, Benkusky NA, Kohr MJ, Valdivia HH, Murphy E, Gyorke S, Ziolo MT. Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation. J Physiol 2010, 588:2905-2917. 10.1113/jphysiol.2010.192617, 20530114.
116. Mickelson JR, Louis CF. Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects. Physiol Rev 1996, 76:537-592.
117. Maclennan DH, Zvaritch E. Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim Biophys Acta 2010,
118. Chelu MG, Goonasekera SA, Durham WJ, Tang W, Lueck JD, Riehl J, Pessah IN, Zhang P, Bhattacharjee MB, Dirksen RT, Hamilton SL. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J 2006, 20:329-330.
119. Benca J, Hogan K. Malignant hyperthermia, coexisting disorders, and enzymopathies: risks and management options. Anesth Analg 2009, 109:1049-1053. 10.1213/ane.0b013e3181adca28, 19762731.
120. Gurnaney H, Brown A, Litman RS. Malignant hyperthermia and muscular dystrophies. Anesth Analg 2009, 109:1043-1048. 10.1213/ane.0b013e3181aa5cf6, 19762730.
121. Zhao F, Li P, Chen SR, Louis CF, Fruen BR. Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity. J Biol Chem 2001, 276:13810-13816.
122. Ali SZ, Taguchi A, Rosenberg H. Malignant hyperthermia. Best Pract Res Clin Anaesthesiol 2003, 17:519-533. 10.1016/j.bpa.2003.09.012, 14661655.
123. Yano M, Yamamoto T, Ikeda Y, Matsuzaki M. Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmia. Nat Clin Pract Cardiovasc Med 2006, 3:43-52. 10.1038/ncpcardio0419, 16391617.
124. Gillard EF, Otsu K, Fujii J, Khanna VK, de Leon S, Derdemezi J, Britt BA, Duff CL, Worton RG, MacLennan DH. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 1991, 11:751-755. 10.1016/0888-7543(91)90084-R, 1774074.
125. Valdivia HH, Hogan K, Coronado R. Altered binding site for Ca2+ in the ryanodine receptor of human malignant hyperthermia. Am J Physiol 1991, 261:C237-245.
126. Ducreux S, Zorzato F, Muller C, Sewry C, Muntoni F, Quinlivan R, Restagno G, Girard T, Treves S. Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J Biol Chem 2004, 279:43838-43846. 10.1074/jbc.M403612200, 15299003.
127. Klingler W, Rueffert H, Lehmann-Horn F, Girard T, Hopkins PM. Core myopathies and risk of malignant hyperthermia. Anesth Analg 2009, 109:1167-1173. 10.1213/ANE.0b013e3181b5ae2d, 19762745.
128. Mathews KD, Moore SA. Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces?. Arch Neurol 2004, 61:27-29. 10.1001/archneur.61.1.27, 14732615.
129. Jungbluth H. Central core disease. Orphanet J Rare Dis 2007, 2:25. 10.1186/1750-1172-2-25, 1887524, 17504518.
130. Bruno C, Minetti C. Congenital myopathies. Curr Neurol Neurosci Rep 2004, 4:68-73. 10.1007/s11910-004-0015-7, 14683632.
131. Loke J, MacLennan DH. Malignant hyperthermia and central core disease: disorders of Ca2+ release channels. Am J Med 1998, 104:470-486. 10.1016/S0002-9343(98)00108-9, 9626031.
132. Avila G, Dirksen RT. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor. The Journal of General Physiology 2001, 118:277-290. 10.1085/jgp.118.3.277, 2229502, 11524458.
133. Boncompagni S, Rossi AE, Micaroni M, Hamilton SL, Dirksen RT, Franzini-Armstrong C, Protasi F. Characterization and temporal development of cores in a mouse model of malignant hyperthermia. Proc Natl Acad Sci USA 2009, 106:21996-22001. 10.1073/pnas.0911496106, 2799858, 19966218.
134. Dirksen RT, Avila G. Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca2+ release channels?. Trends in Cardiovascular Medicine 2002, 12:189-197. 10.1016/S1050-1738(02)00163-9, 12161072.
135. Durham WJ, Aracena-Parks P, Long C, Rossi AE, Goonasekera SA, Boncompagni S, Galvan DL, Gilman CP, Baker MR, Shirokova N, et al. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell 2008, 133:53-65. 10.1016/j.cell.2008.02.042, 2366094, 18394989.
136. Zvaritch E, Kraeva N, Bombardier E, McCloy RA, Depreux F, Holmyard D, Kraev A, Seidman CE, Seidman JG, Tupling AR, MacLennan DH. Ca2+ dysregulation in Ryr1(I4895T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods. Proc Natl Acad Sci USA 2009, 106:21813-21818. 10.1073/pnas.0912126106, 2788482, 19959667.
137. Boncompagni S, Loy RE, Dirksen RT, Franzini-Armstrong C. The I4895T mutation in the type 1 ryanodine receptor induces fiber-type specific alterations in skeletal muscle that mimic premature aging. Aging Cell 2010, 9:958-970. 10.1111/j.1474-9726.2010.00623.x, 20961389.
138. Loy RE, Orynbayev M, Xu L, Andronache Z, Apostol S, Zvaritch E, MacLennan DH, Meissner G, Melzer W, Dirksen RT. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum. The Journal of General Physiology 2011, 137:43-57.
139. Napolitano C, Priori SG, Bloise R, . (Eds) Catecholaminergic polymorphic ventricular tachycardia. 2004, Seattle, WA: University of Washington, Seattle, (Eds).
140. Ylanen K, Poutanen T, Hiippala A, Swan H, Korppi M. Catecholaminergic polymorphic ventricular tachycardia. Eur J Pediatr 2010, 169:535-542. 10.1007/s00431-010-1154-2, 20143088.
141. Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, Mannens MM, Wilde AA, Ackerman MJ. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J Am Coll Cardiol 2009, 54:2065-2074. 10.1016/j.jacc.2009.08.022, 2880864, 19926015.
142. Laitinen PJ, Swan H, Piippo K, Viitasalo M, Toivonen L, Kontula K. Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia. Ann Med 2004, 36(Suppl 1):81-86.
143. Jiang D, Xiao B, Zhang L, Chen SR. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res 2002, 91:218-225. 10.1161/01.RES.0000028455.36940.5E, 12169647.
144. MacLennan DH, Chen SR. Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes. J Physiol 2009, 587:3113-3115. 10.1113/jphysiol.2009.172155, 2727021, 19567749.
145. Kannankeril PJ, Mitchell BM, Goonasekera SA, Chelu MG, Zhang W, Sood S, Kearney DL, Danila CI, De Biasi M, Wehrens XH, et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc Natl Acad Sci USA 2006, 103:12179-12184. 10.1073/pnas.0600268103, 1567715, 16873551.
146. Guo T, Cornea RL, Huke S, Camors E, Yang Y, Picht E, Fruen BR, Bers DM. Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks. Circ Res 2010, 106:1743-1752. 10.1161/CIRCRESAHA.110.219816, 20431056.
147. George CH, Higgs GV, Lai FA. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 2003, 93:531-540. 10.1161/01.RES.0000091335.07574.86, 12919952.
148. Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res 2006, 99:292-298. 10.1161/01.RES.0000235869.50747.e1, 16825580.
149. Cerrone M, Noujaim SF, Tolkacheva EG, Talkachou A, O'Connell R, Berenfeld O, Anumonwo J, Pandit SV, Vikstrom K, Napolitano C, et al. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2007, 101:1039-1048. 10.1161/CIRCRESAHA.107.148064, 2515360, 17872467.
150. Herron TJ, Milstein ML, Anumonwo J, Priori SG, Jalife J. Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2010, 7:1122-1128. 10.1016/j.hrthm.2010.06.010, 20538074.
151. Kang G, Giovannone SF, Liu N, Liu FY, Zhang J, Priori SG, Fishman GI. Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy. Circ Res 2010, 107:512-519. 10.1161/CIRCRESAHA.110.221481, 20595652.
152. Laitinen PJ, Swan H, Kontula K. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms. Eur J Hum Genet 2003, 11:888-891. 10.1038/sj.ejhg.5201061, 14571276.
153. Jiang D, Xiao B, Yang D, Wang R, Choi P, Zhang L, Cheng H, Chen SR. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci USA 2004, 101:13062-13067. 10.1073/pnas.0402388101, 516517, 15322274.
154. Kashimura T, Briston SJ, Trafford AW, Napolitano C, Priori SG, Eisner DA, Venetucci LA. In the RyR2(R4496C) mouse model of CPVT, beta-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves. Circ Res 2010, 107:1483-1489. 10.1161/CIRCRESAHA.110.227744, 20966392.
155. Dorn GW, Molkentin JD. Manipulating cardiac contractility in heart failure: data from mice and men. Circulation 2004, 109:150-158. 10.1161/01.CIR.0000111581.15521.F5, 14734503.
156. Shannon TR, Pogwizd SM, Bers DM. Elevated sarcoplasmic reticulum Ca2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ Res 2003, 93:592-594. 10.1161/01.RES.0000093399.11734.B3, 12946948.
157. Blayney LM, Jones JL, Griffiths J, Lai FA. A mechanism of ryanodine receptor modulation by FKBP12/12.6, protein kinase A, and K201. Cardiovasc Res 2010, 85:68-78. 10.1093/cvr/cvp273, 19661110.
158. Jiang MT, Lokuta AJ, Farrell EF, Wolff MR, Haworth RA, Valdivia HH. Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res 2002, 91:1015-1022. 10.1161/01.RES.0000043663.08689.05, 12456487.
159. MacDonnell SM, Garcia-Rivas G, Scherman JA, Kubo H, Chen X, Valdivia H, Houser SR. Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808. Circ Res 2008, 102:e65-72. 10.1161/CIRCRESAHA.108.174722, 2652487, 18388322.
160. Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res 2005, 97:1314-1322. 10.1161/01.RES.0000194329.41863.89, 16269653.
161. Xiao B, Sutherland C, Walsh MP, Chen SR. Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circ Res 2004, 94:487-495. 10.1161/01.RES.0000115945.89741.22, 14715536.
162. Barg S, Copello JA, Fleischer S. Different interactions of cardiac and skeletal muscle ryanodine receptors with FK-506 binding protein isoforms. Am J Physiol 1997, 272:C1726-1733.